Carregant...
Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report
Novel coronavirus disease 2019 (COVID-19) emerged in late December 2019 in Wuhan, China. Since then, COVID-19 has become a pandemic affecting more than 4.1 million people worldwide. Patients with COVID-19 have a wide spectrum of manifestations, one being cytokine release syndrome (CRS) and its fatal...
Guardat en:
| Publicat a: | Chest |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American College of Chest Physicians
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7195070/ https://ncbi.nlm.nih.gov/pubmed/32343968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2020.04.024 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|